Type of research: basic Duration from: 01/01/91. to 12/31/95. Papers on project (total): 23
Papers on project quoted in Current Contents: 6
Institution name: Pliva - Istraživački institut, Zagreb (60) Department/Institute: Biosynthesis and Biotechnology Address: Prilaz baruna Filipovića 89 City: 10000 - Zagreb, Croatia
Communication
Phone: 385 (0)1 18-15-87
Fax: 385 (0)1 57-47-19
Summary: The available knowledge and results of long term studies of
Streptomyces and Aspergillus in our laboratories as well as the
application of the recent recombinant DNA methods and techniques have
enabled these investigations. For the first time a rapid and reliable
method for transformation of Streptomyces by electroporation has been
published and used in our laboratories. That method has enabled
introduction of various vectors as well as integration and expression of
haemoglobin (VHb) gene from Vitreoscilla in S. rimosus R6 chromosome. The
construction of an S. rimosus R6 strain lacking some enzymes (AT, KS, CLF)
in OTC-polyketide synthase (PKS) is in progress. In parallel,
actinorhodin-PKS genes were introduced into a bifunctional plasmid.
Construction of R6 AT, KS, CLF-deleted strain and its transformation with
plasmids harbouring PKS genes of other polyketide antibiotics are expected
to give novel polyketide molecules. From the industrial Aspergillus niger
strain the glucoamilase gene was isolated and cloned into the different A.
niger strains. Transformants were analysed for the level of glucoamylase
in respect to the glucoamylase gene copy number. The human proinsulin gene
has been also synthesised by means of overlapping, complementary
oligonucleotides in combination with PCR and cloned into two types of
fungal expression vectors. Expression of the human proinsulin gene in
various transformants was determined by insulin radioimmune assay.
Keywords: Streptomyces rimosus, Aspergillus niger, gene expression, homologous and heterologous products, oxytetracycline,polyketide antibiotics, glucoamylase, human insulin
Research goals: Streptomyces and Aspergilli are mycelial
microorganisms similar in distinct differentiation, release of metabolites
into medium, heterokaryon formation etc, and known as antibiotic and
enzyme producers in biotechnology. The aim of this project is to study
gene expression of a primary (glucoamylase) and a secondary (polyketide
antibiotic, oxytetracycline) metabolite in mycelial microorganisms.
Further investigations will comprise the expression of heterologous
products in these microorganisms (new polyketide antibiotic,
pharmaceutical protein). The total sequence of OTC-genes, and availability
of various vectors (autonomous, integrative, bifunctional) enable
introduction and expression of homologous and heterologous genes in these
important microorganisms. The organisation of OTC-genes of mutants blocked
in OTC-biosynthesis in respect to the parental R6 strain will be
revealed. At least some of the mutants lacking the whole OTC-gene cluster
could serve as hosts for introduction of foreign genes. An efficient and
reliable method for transformation of mycelial fragments instead of
protoplasts by electroporation will be elaborated and applied to R6 and
4018 strains. At least one heterologous gene will be introduced possibly
by integration into R6 chromosome to enhance OTC yield. Site-directed
mutagenesis of OTC-PKS genes, construction of various plasmids will enable
construction of strains adequate for biosynthesis of new polyketide
molecules. The aim of this research are the new insight on the glucoamylase
gene regulation and expression, influence of gene copy number on
glucoamylase gene expression, as well as the fungal strain potential for
homologous and heterologous protein expression. To investigate glucoamylase
expression in Aspergillus niger, various co/transformants will be analysed
for the glucoamylase levels in respect to its gene copy number. Chemical
and biochemical methods will be used to construct human proinsulin gene
which will be under control of regulatory sequences of the glucoamylase
gene. Certain modifications will be introduced into the synthetic human
proinsulin gene to study the eventually positive effect on human insulin
expression and secretion.
The knowledge achieved on gene expression during this study is important
for the development of new biotechnology both in PLIVA and in Croatia.
According to many predictions, new biotechnology should become a dominant
technology in the nearest future.
COOPERATION - PROJECTS
Name of project
: 1-08-021 Struktura složenost i stabilnost
genoma streptomiceta Name of institution: Prehrambeno-biotehnološki fakultet City: 10000 - Zagreb, Croatia
Name of project
: ALIS LINK No.007 Molecular genetics of
oxytetracycline biosynthesis from Streptomyces rimosus R6, the
oxytetracycline producer Name of institution: University of Glasgow City: 441 - Glasgow, UK
COOPERATION - INSTITUTIONS
Name of institution
: Prehrambeno-biotehnološki fakultet Type of institution: Economical/Production City: 10000 - Zagreb, Croatia